Investigations of clinical thyroid cancer patients have revealed that TERT promoter mutation is highly correlated with advanced or progressive disease, including advanced tumor stages, extrathyroidal extension, vascular invasion, lymph node metastases, distant metastases, and recurrence [100,101,104,105,110,114,117]. The gene discussed is TERT; the disease is thyroid gland carcinoma.